Related Experiment Video
Updated: Aug 17, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria
Olav Gressner1, Tobias Schilling, Katja Lorenz
1Department of Internal Medicine IV, Hepatology and Gastroenterology, University Hospital, Heidelberg, Germany.
Abstract:
TP63, an important epithelial developmental gene, has significant homology to p53. Unlike p53, the expression of p63 is regulated by two different promoters resulting in proteins with opposite functions: the full-length transcriptionally active TAp63 and the dominant-negative DeltaNp63. We investigated the downstream mechanisms by which TAp63alpha elicits apoptosis. TAp63alpha directly transactivates the CD95 gene via the p53 binding site in the first intron resulting in upregulation of a functional CD95 death receptor. Stimulation and blocking experiments of the CD95, TNF-R and TRAIL-R death receptor systems revealed that TAp63alpha can trigger expression of each of these death receptors. Furthermore, our findings demonstrate a link between TAp63alpha and the mitochondrial apoptosis pathway. TAp63alpha upregulates expression of proapoptotic Bcl-2 family members like Bax and BCL2L11 and the expression of RAD9, DAP3 and APAF1. Of clinical relevance is the fact that TAp63alpha is induced by many chemotherapeutic drugs and that inhibiting TAp63 function leads to chemoresistance. Thus, beyond its importance in development and differentiation, we describe an important role for TAp63alpha in the induction of apoptosis and chemosensitivity.
Insights
The tumor protein 63 (TP63) alpha isoform induces apoptosis by upregulating death receptors and mitochondrial pathways. This TAp63alpha function is crucial for chemotherapy effectiveness, as its inhibition leads to chemoresistance.
Area of Science:
- Molecular Biology
- Cell Death Pathways
- Cancer Biology
Background:
- TP63 is a key epithelial developmental gene homologous to p53.
- TP63 produces two functional variants: TAp63 (transcriptionally active) and DeltaNp63 (dominant-negative).
- The distinct roles of TAp63 isoforms in apoptosis and cancer therapy remain incompletely understood.
Purpose of the Study:
- To elucidate the downstream molecular mechanisms by which TAp63alpha induces apoptosis.
- To investigate the role of TAp63alpha in regulating death receptor pathways and mitochondrial apoptosis.
- To determine the clinical relevance of TAp63alpha in chemotherapy sensitivity.
Main Methods:
- Investigated TAp63alpha's direct transactivation of the CD95 gene.
- Utilized stimulation and blocking experiments on CD95, TNF-R, and TRAIL-R death receptor systems.
- Analyzed TAp63alpha's effect on proapoptotic Bcl-2 family members and mitochondrial apoptosis regulators.
Main Results:
- TAp63alpha directly upregulates the CD95 death receptor via its promoter.
- TAp63alpha activates expression of multiple death receptors (CD95, TNF-R, TRAIL-R) and mitochondrial apoptosis factors (Bax, BCL2L11, RAD9, DAP3, APAF1).
- TAp63alpha is induced by chemotherapeutic drugs, and its inhibition confers chemoresistance.
Conclusions:
- TAp63alpha plays a significant role in inducing apoptosis through both death receptor and mitochondrial pathways.
- TAp63alpha is a critical mediator of chemosensitivity.
- Targeting TAp63alpha may offer novel strategies for overcoming chemoresistance in cancer treatment.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis
Cellular Injury V: Apoptosis and Autophagy
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Caspases

